Social Media Ideas for Cofrx

SFM

SFM Anonymous (not verified) Wed, 06/10/2026 - 20:50 field_thread_url https://cafepharma.com/boards/threads/sfm.701491/ board name...

<![CDATA[Pharmaceutical Executive Daily: FDA Sends Complete Response Letter for Cingulate's CTx-1301]]>

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at...

<![CDATA[FDA Sends CRL to Cingulate for CTx-1301]]>

SFM

SFM Anonymous (not verified) Sun, 06/14/2026 - 20:54 field_thread_url https://cafepharma.com/boards/threads/sfm.701491/ board name...

This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million

This clinical-stage biotech develops oral therapeutics for chronic diseases, with a pipeline centered on metabolic and pulmonary targets.

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase

Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related conditions.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at...

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Xocova]]>

Corxel gears up for global pivotal push after oral GLP-1 posts ‘competitive’ ph. 2 results

With a balance of competitive efficacy and tolerability, Corxel figures it has a potential winner to take into late-stage development.

<![CDATA[Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo]]>

Fast Moving Consumer Goods, Inc. Welcomes Calmara, a New Functional Wellness Beverage, to Its CPG Incubator

Fast Moving Consumer Goods, Inc. expands its national CPG incubator with Calmara Beverage Company, bringing a physician-founded functional wellness beverage inspired by focus, clar...

Cooper (COO) Q2 2026 Earnings Transcript

Image source: The Motley Fool. DateThursday, June 4, 2026 at 5 p.m. ETCall participantsPresident and Chief Executive Officer — Albert WhiteChief Financial Officer and Treasurer —...

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Key Insights from HNSCC KOL Event Transcript

ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin Surge

This specialty pharma company, known for its branded and generic drug portfolio, just reported a notable insider sale in the latest filing.

<![CDATA[CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo]]>

Cohort plc 2026 Q4 - Results - Earnings Call Presentation

Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter

Alumis develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases through proprietary TYK2 inhibitors.

GoodRx Holdings, Inc. (GDRX) Strengthens Recurring Revenue Base with Companion

Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able

Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook

William Guyer's pre-scheduled disposition under a Rule 10b5-1 plan liquidates some direct holdings while retaining 130,000 derivative securities.

Covalon Technologies Ltd. (COV:CA) Q2 2026 Earnings Call Transcript

RxSight: Alcon Deal Reshapes The Long-Term Growth Story

Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target